Exane Derivatives’s Campbell Soup CPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$480 Hold
10
﹤0.01% 574
2022
Q1
$446 Hold
10
﹤0.01% 876
2021
Q4
$435 Hold
10
﹤0.01% 783
2021
Q3
$418 Sell
10
-9,996
-100% -$434K ﹤0.01% 956
2021
Q2
$447K Buy
10,006
+352
+4% +$17K 0.1% 206
2021
Q1
$485K Sell
9,654
-194
-2% -$9.24K 0.14% 153
2020
Q4
$476K Sell
9,848
-689
-7% -$33.3K 0.14% 168
2020
Q3
$510K Buy
10,537
+1,157
+12% +$57.1K 0.15% 128
2020
Q2
$466K Buy
9,380
+8,930
+1,984% +$444K 0.12% 141
2020
Q1
$20.8K Hold
450
0.01% 406
2019
Q4
$21.5K Buy
450
+391
+663% +$18.5K ﹤0.01% 390
2019
Q3
$2.77K Sell
59
-3,985
-99% -$172K ﹤0.01% 471
2019
Q2
$162K Sell
4,044
-614
-13% -$24.1K 0.03% 290
2019
Q1
$178K Buy
4,658
+867
+23% +$30.6K 0.04% 231
2018
Q4
$125K Hold
3,791
0.02% 296
2018
Q3
$138K Buy
+3,791
New +$154K 0.03% 286
2016
Q2
Sell
-220,125
Closed -$14M 573
2016
Q1
$14M Sell
220,125
-114,181
-34% -$6.71M 1.86% 21
2015
Q4
$17.6M Buy
+334,306
New +$17.1M 2.41% 13

Other funds holding CPB

Exane Derivatives's CPB Position: Q2 2022 in Review

Exane Derivatives held its Campbell Soup (CPB) position steady in Q2 2022 at 10 shares worth $480. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Exane Derivatives first reported a position in CPB in Q4 2015 and has held it in 18 quarters since. The position peaked at $17.6M in Q4 2015. 566 funds tracked by Wall St. Rank hold CPB as of Q2 2022.

  • Exane Derivatives held 10 shares of Campbell Soup worth $480 as of Q2 2022.
  • Exane Derivatives left its Campbell Soup share count unchanged in Q2 2022.
  • Campbell Soup made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #574 holding.
  • Exane Derivatives first reported a position in Campbell Soup in Q4 2015 and has held it in 18 quarters since.
  • Exane Derivatives's Campbell Soup position peaked at $17.6M in Q4 2015.
  • 566 funds tracked by Wall St. Rank held Campbell Soup as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.